Corcept Therapeutics Inc
CORT· Nasdaq
Released Mar 10, 2016, after the close
10-K filed Mar 10, 2016, 70 days after period end · 0001088856-16-000011
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|
| Revenue | $14.97M | $9.01M | $4.12M | $1.38M |
| Net Income | $959.00K | -$3.90M | -$11.12M | -$11.12M |
| EPS Diluted | $0.01 |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| -$0.04 |
| -$0.11 |
| -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.